Personalis, Inc. - Common Stock (NQ:PSNL)

16.00 UNCHANGED

Delayed Quote Updated: 2:05 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

August 26, 2021

From Personalis, Inc.

Via Business Wire

Personalis Announces Corporate Headquarters Expansion to Accelerate Growth in Laboratory Operations and Research & Development

August 25, 2021

From Personalis

Via Business Wire

Return on Capital Employed Insights for Personalis ↗

August 20, 2021

Pulled from Benzinga Pro data Personalis (NASDAQ:PSNL) reported Q2 sales of $21.67 million. Earnings fell to a loss of $14.95 million, resulting in a 19.67% decrease from last...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 19, 2021

Thursday morning, 173 companies reached new 52-week lows. Areas of Interest: The largest company by market cap to set a new 52-week low was Alibaba Group Holding (...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 20, 2021

On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...

Via Benzinga

Recap: Personalis Q2 Earnings ↗

August 04, 2021

Shares of Personalis (NASDAQ:PSNL) fell 1.8% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 17.24% year over year to...

Via Benzinga

Personalis Reports Second Quarter 2021 Financial Results

August 04, 2021

From Personalis, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

August 17, 2021

Tuesday morning, 282 companies set new 52-week lows. Key Facts: Alibaba Group Holding (NYSE:BABA) was the biggest company by market cap to set a new 52-week low....

Via Benzinga

Earnings Scheduled For August 4, 2021 ↗

August 04, 2021

Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to...

Via Benzinga

Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

August 03, 2021

From Personalis, Inc.

Via Business Wire

Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients

August 02, 2021

From Personalis, Inc.

Via Business Wire

Personalis to Announce Second Quarter Financial Results on August 4, 2021

July 21, 2021

From Personalis, Inc.

Via Business Wire

Personalis Announces NeXT Level Biomarkers Symposium

June 22, 2021

From Personalis, Inc.

Via Business Wire

Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program

June 02, 2021

From Personalis, Inc.

Via Business Wire

Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit

May 18, 2021

From Personalis, Inc.

Via Business Wire

Personalis, Inc. to Present at Biomarkers Week Online 2021

May 17, 2021

From Personalis, Inc.

Via Business Wire

Personalis Reports First Quarter 2021 Financial Results

May 05, 2021

From Personalis, Inc.

Via Business Wire

Personalis to Present at the 2021 Bank of America Healthcare Conference

April 29, 2021

From Personalis, Inc.

Via Business Wire

Personalis to Report First Quarter 2021 Financial Results on May 5, 2021

April 21, 2021

From Personalis, Inc.

Via Business Wire

Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®

April 08, 2021

From Personalis, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.